Mutations can reduce effect of hormonal treatment in early breast cancer
A new study identifies interleukin 11 as a marker of cancer-associated fibroblasts
22 April 2021Antidepressants: Evidence on safe discontinuation is lacking, concludes Cochrane review
22 April 2021Mutations can reduce effect of hormonal treatment in early breast cancer
A small proportion of women who receive anti-estrogen treatment after breast cancer surgery have worse outcomes. This is associated with mutations in the estrogen receptor gene, according to a study from Lund University now published in JNCI Cancer Spectrum.
